Peter D. Kwong and Xuejun Chen are not included in the author byline. Xuejun Chen should be listed as the fifth author and Peter D. Kwong should be listed as the fifteenth author. Both are affiliated with Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA. The contributions of these authors are as follows: Investigation, Resources.
Reference
- 1. LaBranche CC, McGuire AT, Gray MD, Behrens S, Zhou T, Sattentau QJ, et al. (2018) HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies. PLoS Pathog 14(11): e1007431. https://doi.org/10.1371/journal.ppat.1007431 pmid:30395637
Citation: LaBranche CC, McGuire AT, Gray MD, Behrens S, Chen X, Zhou T, et al. (2019) Correction: HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies. PLoS Pathog 15(3): e1007646. https://doi.org/10.1371/journal.ppat.1007646
Published: March 26, 2019
Copyright: © 2019 LaBranche et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.